Conformis Inc (NASDAQ:CFMS) CEO Mark Augusti joined Proactive's Stephen Gunnion with details of the orthopedic technology company's proprietary technology that enables it to create 3D models using CT scans to develop knee implants that are specific for the patient.
Conformis is the only company that offers an FDA-approved fully personalized total knee arthroplasty product.
"We have developed our technology over the last 15-20 years, we've done over 100,000 patients, and we have the highest patient satisfaction score in the industry," Augusti said. "We're excited about what we do ... we're making patients' lives better every day."